ASX 200

Major broker Morgan Stanley is concerned that the recent rally in the iron ore price post-China stimulus announcements may be unsustainable.

Can you have it all? Chris Conway and Carl Capolingua bring you their list of ASX stocks with great earnings, value, and technicals.

The Forager team undertook a research trip to Japan a couple of months ago, meeting more than 50 companies. Here's two that stood out.

Gold prices are on a record streak of all-time highs. So why are gold stocks struggling for upside?

I recently returned from the USA, spending a week travelling across five states from the West Coast to the East Coast and seeing over 25 companies. The purpose of...

Aussie bank shares have been some of the best performers in the S&P/ASX200 over the last 12 months, but can their amazing run continue?

Janus Henderson’s Daniel Sullivan explains why uranium's renaissance is worth watching.

Despite analyst concerns, the banks have kept climbing. Are passive funds to blame for this climb?

Rio Tinto seems ready to capitalise on the long-term new energy thematic and the incremental value it can generate.

If inflation won't go away, which investments will perform and what should you avoid?

The companies these fundies believe will help investors ride a downturn.

ASX lithium stocks are about to enter their third year of general decline. Most of the major lithium names are down in order of magnitude 70-90% from the highs set in...

Ray David discusses the importance of Governance, and four Founder led ASX businesses to keep an eye on.

Qantas shares are flying high after a well-received trading update. What do the big brokers think about the stock now? Buy, hold, or sell?

While small caps have underperformed the past three years, we think valuations are looking attractive and the time is right to invest.

The ASX stocks that enjoyed the biggest upgrades and price target increases this week (plus those shunned with downgrades and cuts!)

First Sentier's David Wilson shares insights from 40 years of stock-picking experience.

High multiples on the ASX are presenting a painful scenario that has played out multiple times before says Lazard's Dr Philipp Hofflin.

Playing a pivotal role in Australia’s health transition.

In this episode, Antipodes' Jacob Mitchell and Magellan's Arvid Streimann analyse five stocks that could benefit from lower rates.

In this Fund in Focus, Charter Hall's Steve Bennett walks us through the value he is finding in the ASX-listed REITs sector.

Our key insights from a week of visiting companies in Western Australia, with 5 actionable ideas

Charter Hall’s Steve Bennett highlights a stock with a $40 billion funds management business that is basically priced at nothing.

Global bull market lifts Australia to fresh highs